HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis.

AbstractBACKGROUND:
Patients with rheumatoid arthritis (RA) have greater rates of cardiovascular mortality and RA is an independent cardiovascular risk factor. For the management of cholesterol, the American College of Cardiology/American Heart Association (ACC/AHA) developed new guidelines for the general population. None of the European or American guidelines are specific to RA. The European League Against Rheumatism (EULAR) recommends applying a coefficient to cardiovascular risk equations based on the characteristics of RA. Our objective was to compare the three different sets of guidelines for the eligibility of statin therapy in RA-specific population with very high risk of cardiovascular disease.
METHODS AND RESULTS:
We calculated the proportion of patients eligible for statins according to the guidelines of the European Society of Cardiology (ESC), the Adult Treatment Panel III (ATP-III) and the ACC/AHA in a French cohort of statin-naïve RA patients at least 40 years age. Of the 547 women and 130 men analyzed, statins would be recommended for 9.1% of the women and 26.4% of the men, 15.6% of the women and 53.1% of the men, 38.8% of the women and 78.5% of the men, according to the ESC, ATP-III and ACC/AHA guidelines respectively.
CONCLUSIONS:
In RA patients, as has been observed in the general population, discordance in risk assessment and cholesterol treatment was observed between the three sets of guidelines. The use of the new ACC/AHA guidelines would expand the eligibility for statins and may be applied to RA population a condition at very high risk of cardiovascular disease.
AuthorsAnne Tournadre, Zuzana Tatar, Bruno Pereira, Maxime Chevreau, Laure Gossec, Philippe Gaudin, Martin Soubrier, Maxime Dougados
JournalInternational journal of cardiology (Int J Cardiol) Vol. 183 Pg. 149-54 (Mar 15 2015) ISSN: 1874-1754 [Electronic] Netherlands
PMID25666124 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015. Published by Elsevier Ireland Ltd.
Chemical References
  • Amino Acids
  • statine
Topics
  • Adult
  • Aged
  • American Heart Association
  • Amino Acids (therapeutic use)
  • Arthritis, Rheumatoid (drug therapy, physiopathology)
  • Cardiology (methods, standards)
  • Cardiovascular Diseases (prevention & control)
  • Cohort Studies
  • Dyslipidemias (therapy)
  • Female
  • France
  • Humans
  • Male
  • Middle Aged
  • Practice Guidelines as Topic
  • Risk Assessment
  • Risk Factors
  • Risk Management
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: